All data are based on the daily closing price as of April 28, 2025
g

Grape King Bio

1707.TW
4.20 USD
0.00
0.00%

Overview

Last close
4.20 usd
Market cap
622.87M usd
52 week high
5.08 usd
52 week low
3.91 usd
Target price
5.53 usd

Valuation

P/E
14.0577
Forward P/E
17.3611
Price/Sales
1.8318
Price/Book Value
2.0109
Enterprise Value
491.36M usd
EV/Revenue
1.4292
EV/EBITDA
5.0001

Key financials

Revenue TTM
343.81M usd
Gross Profit TTM
266.71M usd
EBITDA TTM
90.36M usd
Earnings per Share
0.3 usd
Dividend
N/A usd
Total assets
467.37M usd
Net debt
N/A usd

About

Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally. It operates through Multi-Level Marketing; Distributors; Original Design Manufacturer/Original Equipment Manufacturer; and Sales Channel segments. The company offers Chinese herbal medicines, probiotics, energy drinks, and health food supplements for gastrointestinal health, immunity regulation, female beauty, and health care. It also provides functional ingredients for intestinal care, weight control, liver care, brain health, eye care, feminine health, and sensual health care; and microbial fermentation, as well as food inspection services. In addition, the company offers health foods, beverages, cosmetics, and general and pet food. Grape King Bio Ltd was founded in 1969 and is headquartered in Taoyuan City, Taiwan.
  • Symbol
    1707.TW
  • Exchange
    TW
  • Isin
    TW0001707008
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Bing-Jyun Cuei
  • Headquarter
    Taoyuan City
  • Web site
    https://www.grapeking.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top